Clinical Trial Update: OPTImal Management of Antithrombotic Agents: OPTIMA-2 Trial [Phase 4]

View source ↗

Summary

Phase 4 trial update on OPTIMA-2 for management of antithrombotic agents in coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED